indicators for the Clearing House and the measures could complement indicators on clinical quality of providers from the NIH Promis initiative in the United States (or the NHS Proms in the UK). METHODS: The concept development is relevant for chronic care. Five domains represent outpatient drug care: information, communication access, trust and clinical quality. Four process measures and one access measure are proposed with series of 5 -7 items, tested on pharmacy delivery systems and dispensing doctors.The trust indicator has been identified as critical for the US drug delivery system and discussed as an example. RESULTS: Trust adresses the potential patient mistrust when cost interfere with clinical judgement. The process measure is calculated for prescribing and treatment decisions for Hypertension, Diabetes and Asthma.It is a rate base measure . The Facct scoring method is modified to integrate minima in low score values. Mean scores are calculated on samples per practice. Missing values are replaced by mean value. The evidence from the UK PCT on a scale of 0-100, for three practices show scores of 66.78; 63.82;73.92 and 67.72 
OBJECTIVES:
To serve as comparative data for percutaneous valve replacements, this study sought to characterize the historical outcomes for aortic and mitral valve replacement surgery in a large, nationally representative population. METHODS: Patients undergoing aortic or mitral valve replacement were identified from the 5% national Medicare data (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) using ICD-9-CM codes 35.21 to 35.24. The subsequent rates of mortality, mechanical complications, infection, and valve re-implantation/reoperation, and infective endocarditis were evaluated. Hospitalization charges and reimbursements (in Jan 2011 dollars) for the index procedure were also assessed. RESULTS: The patient cohort included 12,202 aortic bioprosthesis, 9,757 aortic mechanical valves, 3,222 mitral bioprosthesis, and 4,401 mitral mechanical valves. The ten-year Kaplan-Meier mortality, mechanical complication, infection, re-implantation/reoperation, and infective endocarditis rates for aortic bioprosthesis were 64.4%, 4.41%, 4.54%, 1.50%, and 8.34%, respectively, and for aortic mechanical valves were 63.9%, 5.23%, 4.71%, 1.84%, and 9.08%, respectively. The corresponding ten-year Kaplan-Meier rates for mitral bioprosthesis were 74.8%, 8.02%, 6.29%, 2.81%, and 12.90%, respectively, and for mitral mechanical valves were 64.7%, 7.60%, 6.06%, 2.87%, and 12.24%, respectively. The average hospitalization reimbursements for procedures involving aortic bioprostheses, aortic mechanical valves, mitral bioprostheses, and mitral mechanical valves were $54.3k, $54.6k, $64.1k, and $62.2k, respectively. CONCLUSIONS: The crude risks of mortality and complications, as well as payer costs, were found to be higher for mitral valve replacements compared with aortic valve replacements. This study provides baseline data for evaluating the comparative effectiveness of percutaneous valve replacement to "traditional" approaches, especially since the percutaneous approach may have inherently different levels of performance or expanded indications. Perikhanyan A Nork Marash Medical Center, Yerevan, Armenia OBJECTIVES: The importance of avoiding unnecessary diagnostic invasive angiography is emphasized based on risks associated with test and costs. At the same time, early interventions are important to reduce negative outcomes of coronary artery disease (CAD). Objective of this study was to analyze the characteristics and outcomes of cases with possible CAD that underwent coronary angiography catheterization (CAG) from December 2006 to February 2007 consecutively in Nork Marash Medical Center (NMMC). METHODS: This was a retrospective study of newly admitted cohort. Predefined exclusion criteria were CAG in other clinic, CAG for other then CAD reasons and non Armenian residency. RESULTS: Only 200 records were corresponding to the criteria. The mean age of cases was 52.91Ϯ10 years and 85% were males (RRϭ0.93). The mean age of women was higher (Ϸ60 vs Ϸ50). Only 10.5% of participants had normal BMI. Current smokers comprised 60 %( RRϭ1.17), 74% had hypertension (RRϭ1.165), 30.5% hypercholesterolemia (RRϭ2.5) and 14.5% Diabetes Mellitus (RRϭ4.26). In 26(13%) cases catheterization detected no CAD at all and 13(6.5%) patients had stenosisϽ50%. Most catheterizations were elective (68%).There were 2 urgent admissions among patients with CADϽ50%. Significantly diseased left anterior descending (LAD) proximal was detected most frequently (52%).Among patients with stenosisՆ50% 24% of cases underwent PCI, 75% CABG, and 5% bridge to CABG procedure. Thirty two people (20%) were not treated with revascularization: among them 7 (21.9%) with multivessel disease. 15% of patients with indication to revascularization refused to be treated with any of procedures. CONCLUSIONS: There is gender inequality in CAG utilization, early cholesterol control should be encouraged by primary care professionals, patient preferences play significant role in a treatment decision process in Armenia.
PMD2 ADMISSION TO CORONARY ANGIOGRAPHIC CATHETERIZATION IN ARMENIA AT NORK MARASH MEDICAL CENTER: CHARACTERISTICS AND OUTCOMES

PMD3 DOES CURRENT PERCEPTION THRESHOLD TEST CAN DIFFERENTIATE CATEGORIES OF MECHANICAL NECK DISORDER?
OBJECTIVES: To differentiate three types of Mechanical Neck Disorders (MND) by Current Perception Threshold (CPT). Specific aims were to: 1) Look whether differences in CPT exist in MND categories, and 2) Estimate the predicted probability of the neurological symptoms in type-3 of MND. METHODS: The study design was a laboratory based cross-sectional discriminative analysis. Patients with MND (N ϭ 106) were assessed for CPT into three groups: MND-mixed (Nϭ60), MND-2 (Nϭ29), MND-3 (Nϭ17). CPT testing was performed in a standard Quantatative Sensory Testing laboratory. A one-way ANOVA with post hoc was done for compare the mean CPT score between the groups. An independent sample t-test was done to compare the mean CPT and estimated effect size between MND-2 and MND-3 group. The discriminative analysis predicted the group membership in one of the categories. A binary logistic regression model predicted probability of higher CPT in MND-3, where CPT score counted as the risk factor to having neurological symptoms. A Receiver Operating Characteristic (ROC) curve was created from predicted probability by binary covariate. RESULTS: Mean CPT differed significantly across the three groups (F 2, 96 ϭ 6.69, p ϭ 0.002), with a significant higher preference rating in MND-3 (p ϭ 0.004). Moderate discriminates and a small to medium effect size found between the MND-2 and MND-3. Model discrimination (between MND-2 and MND-3) showed 86.2% specificity and 64.7% sensitivity, where an area under the ROC curve was 0.836 (95% CI ϭ 0.716 -0.956, p ϭ 0.000). CONCLUSIONS: CPT test was capable of differentiate MND categories. CPT might be a potential tool for evaluating neurological involvement or hypersensitivity in neck pain.
PMD4 QUALITATIVE MOLECULAR TESTS FOR CONFIRMATION OF THE DIAGNOSIS OF HEPATITIS C IN SEROPOSITIVE PATIENTS: A SYSTEMATIC REVIEW
Oliveira IG, Pereira C, Portela M Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil OBJECTIVES: Hepatitis C represents a serious Public Health problem. In approximately 80% of cases, the disease becomes chronic and the diagnosis can sometimes be made before the disease becomes severe. In 1993, the Brazilian government adopted a screening system with serological kits for hepatitis C diagnosis in blood donors. A positive screening, however, should be confirmed with another type of test since they do not distinguish active infection from past infection. So, molecular tests are very important to establish actual viremia and the hepatitis c diagnosis. Many guidelines throughout the world recommend the molecular test in various settings, including the confirmation of HCV in seropositive people. There are different qualitative molecular tests available for detecting HCV. The aim of this study was to conduct a systematic review of the accuracy of these different tests for confirmation of the diagnosis of HCV in seropositive people. METHODS: We searched MEDLINE, SCOPUS and the Cochrane Library. QUADAS was the tool used for quality assessment of the studies. RESULTS: The search resulted in 1222 articles for evaluation. Only 2 studies were included in the systematic review, according to the established inclusion and exclusion criteria. Both COBAS AMPLICOR and AM-PLICOR tests had high sensitivity and specificity in one of the studies. The second study, presented accuracy data regarding an "in house" PCR test, which presented overall accuracy of 75%. CONCLUSIONS: Although we identified many articles in our search, the vast majority addressed analytical sensitivity, therefore not meeting our criteria, especially because they did not present accuracy data according to an established a gold standard. Furthermore, the 2 studies included did not present a good methodological quality according to QUADAS. These findings show the urgent need of studies with appropriate design for extraction of accuracy data of molecular tests. 
PMD5 USE AND FINDINGS OF K-RAS IN COLORECTAL CANCER (CRC) TESTING IN ADMINISTRATIVE AND ELECTRONIC MEDICAL RECORDS (EMR) DATA FROM 2005 THROUGH 2010
OBJECTIVES:
The aim of this study is to evaluate the accuracy of non-invasive diagnosis methods for ischemic heart disease in patients with chest pain. METHODS: A retrospective cohort study was performed on new patients who have not received any diagnosis of ischemic heart disease or treatment before among those over 30 years of age who visited the cardiology outpatient clinic between 2006 to 2008 in a single medical institution. Among non-invasive diagnostic methods, stress ECG(sECG), myocardial SPECT, and CT coronary angiography(CTCA) were included in our study. Since coronary angiography(CAG) was not performed in all patients, the comparison of test accuracy was calculated by correcting referral bias to CAG depending on non-invasive test results based on the Bayes Theorem, and by reflecting the 1-year follow-up results. RESULTS: Among 4743 patients selected, 2485 patients received more than one of the following non-invasive tests: sECG, SPECT, and CTCA for differential diagnosis. sECG was performed in 853 patients(34.3%), SPECT in 997 patients(40.1%), and CTCA in 635 patients(25.6%). A total of 592 patients(23.8%) received CAG among the 2485 patients. Test indices adjusted for referral bias using the 2 methods were a sensitivity of 49% or 80% in sECG, 46% or 75% in SPECT and 57% or 88% in CTCA, a specificity of 65% or 62%, 81% or 78% in SPECT and 96% or 81% in CTCA. A likelihood ratio for a positive test were 1.39 or 2.08 in sECG, 2.47 or 3.38 in SPECT and 14.14 or 4.65 in CTCA, and a likelihood ratio for a negative test were 0.79 or 0.33 in sECG, 0.66 or 0.32 in SPECT and 0.45 or 0.14 in CTCA. CONCLUSIONS: In conclusion, the accuracy of diagnosing ischemic heart disease was the highest in CTCA, followed by myocardial SPECT and sECG by correcting referral bias to CAG.
PMD7 LONG-TERM CLINICAL OUTCOMES AFTER CORONARY BARE-METAL AND DRUG-ELUTING STENTING
Yin S, Parente AK, Teigland C, Jones BT, Wang RH MedAssurant Inc., Bowie, MD, USA OBJECTIVES: To evaluate long-term clinical outcomes of elderly Medicare beneficiaries who underwent non-emergent coronary stenting. METHODS: This population-based prospective study analyzed patients in a large nationally representative administrative claims database. The sample consisted of Medicare patients aged 65ϩ who underwent a non-emergent coronary stent between 2006 and 2010. Patients were identified by existence of a hospital claim for a bare metal stent (ICD-9-CM procedure code 36.06) or drug-eluting stent (ICD-9-CM procedure code 36.07 or codes 36.06 and 36.07). Eligible patients were followed one to five years after stenting to assess risk of revascularization, myocardial infarction (MI), coronary artery bypass surgery (CABG), and death. Long-term clinical outcomes were based on HEDIS 2010 technical specifications. RESULTS: The study population included 26,023 patients that underwent a coronary bare-metal stent (female ϭ 40.15%, age ϭ 75.38 (Ϯ 6.66), history of MI ϭ 7.97%, history of CABG ϭ 1.01%) and 74,448 patients that underwent a coronary drug-eluting stent (female ϭ 40.17%, age ϭ 73.78 (Ϯ 6.19), history of MI ϭ 7.39%, history of CABG ϭ 1.27%). Patients with drug-eluting stents had a lower risk of revascularization (29.57% vs. 31.65%, p Ͻ 0.001), CABG (1.40% vs. 2.57%, p Ͻ 0.001), and mortality (4.96% vs. 9.25%, p Ͻ 0.001) within one year follow-up after stenting. There was no significant difference in the risk for MI within one to four years follow-up (3.35% vs. 3.29%, p Ͼ 0.05), but there was a significant difference in risk of MI at five year follow-up (7.33% vs. 3.36%, p Ͻ 0.001). Mortality rates significantly increased over time in patients with a bare-metal stent while mortality rates for those with a drug-eluting stent remained relatively stable. CONCLUSIONS: The use of drug-eluting stents was significantly correlated with a decline in long-term risk of revascularization, CABG, MI and death in comparison to bare-metal stents.
